Life Healthcare Group Holdings Limited (JSE:LHC)

JSE:LHC Ratios and Metrics

Market cap in millions ZAR. Fiscal year is October - September.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 18, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	17,001	16,714	23,043	29,250	25,086	33,131
Market Cap Growth	-15.79%	-27.47%	-21.22%	16.60%	-24.28%	33.52%
Enterprise Value	21,327	21,181	18,014	43,612	37,061	45,484
Last Close Price	11.88	10.99	11.66	9.28	7.72	10.01

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 18, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
PE Ratio	12.66	4.43	4.86	110.80	16.39	18.89
Forward PE	8.65	8.57	13.79	15.92	11.27	15.10
PS Ratio	0.66	0.66	0.96	1.28	1.21	1.22
PB Ratio	1.42	1.38	1.71	1.37	1.26	1.73
P/TBV Ratio	1.87	1.85	2.57	1.73	11.24	19.68
P/FCF Ratio	5.91	4.93	6.54	8.46	8.59	9.65
P/OCF Ratio	3.79	3.33	4.78	6.26	6.00	6.44
PEG Ratio	1.24	2.14	0.84	1.05	0.53	0.36

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 18, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
EV/Sales Ratio	0.83	0.83	0.75	1.91	1.79	1.68
EV/EBITDA Ratio	5.56	5.98	5.40	12.95	12.03	10.28
EV/EBIT Ratio	8.07	8.38	7.47	17.52	15.98	15.68
EV/FCF Ratio	7.42	6.25	5.12	12.62	12.69	13.24

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 18, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Debt / Equity Ratio	0.40	0.33	0.33	0.62	0.69	0.68
Debt / EBITDA Ratio	1.26	1.06	1.25	3.74	4.24	2.65
Debt / FCF Ratio	1.67	1.17	1.25	3.82	4.68	3.80
Net Debt / Equity Ratio	0.31	0.01	0.14	0.58	0.55	0.54
Net Debt / EBITDA Ratio	1.01	0.04	0.59	3.66	3.53	2.35
Net Debt / FCF Ratio	1.28	0.04	0.56	3.57	3.72	3.02
Asset Turnover	1.09	1.01	0.69	0.52	0.50	0.65
Inventory Turnover	43.30	41.97	37.63	31.74	24.07	24.52
Quick Ratio	1.24	1.03	1.22	0.38	0.91	0.83
Current Ratio	1.45	1.20	1.43	2.63	1.02	0.94
Return on Equity (ROE)	14.29%	-10.45%	8.82%	6.94%	7.63%	9.44%
Return on Assets (ROA)	7.03%	6.32%	4.31%	3.54%	3.49%	4.34%
Return on Invested Capital (ROIC)	11.45%	18.22%	6.95%	5.78%	5.22%	6.86%
Return on Capital Employed (ROCE)	13.70%	13.60%	12.60%	7.20%	6.70%	8.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 18, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Earnings Yield	39.80%	23.12%	20.95%	0.90%	6.10%	5.29%
FCF Yield	16.92%	20.27%	15.29%	11.82%	11.64%	10.37%
Dividend Yield	6.08%	5.10%	4.29%	4.74%	5.18%	2.50%
Payout Ratio	62.23%	135.43%	196.23%	233.33%	38.34%	-
Buyback Yield / Dilution	0.29%	0.50%	0.75%	0.00%	0.30%	0.09%
Total Shareholder Return	6.37%	5.59%	5.04%	4.74%	5.48%	2.58%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 19, 2026

Data Sources Report a data error